Codiak Biosciences, Inc.

Codiak Biosciences, Inc.

Codiak Biosciences, Inc.

Overview
Date Founded

2015

Headquarters

500 Technology Square 9th Floor Cambridge MA 02139

Type of Company

Private

Employees (Worldwide)

1 - 10

Industries

Other Business & Consulting Services
Pharmaceuticals
Medical Support Services
Biotechnology
Holding Companies

Company Description

Codiak BioSciences, Inc. develops exosomes. It engages in harnessing exosomes, therapeutic applications, diagnostic applications, and proprietary production. The company develops engEx Platform, proprietary and versatile exosome engineering and manufacturing platform, to expand upon the innate properties of exosomes to design novel exosome therapeutics. The company was founded by Douglas E. William, Raghu Kalluri, and Eric S. Lander in 2015 and is headquartered in Cambridge, MA.

Contact Data
Trying to get in touch with decision makers at Codiak Biosciences, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Founding President & Chief Executive Officer

Chief Financial Officer

Chief Legal Officer

Executive Vice President & Head of Research & Development

Senior Vice President, Head of Experimental Medicine & Neurology

Chief Business Officer & Head-Strategy

Senior Vice President & Head-Clinical Development

Director of Science Operations

Senior Clinical Coordinator

Board of Directors

Managing Director at ARCH Venture Partners

President & Director at The Broad Institute, Inc.

Founding President & Chief Executive Officer at Codiak Biosciences, Inc.

Faculty Director of the Deshpande Center for Technological Innovation at Massachusetts Institute of Technology

Executive Partner at Mpm Capital LLC

General Partner at Flagship Pioneering

Co-Founder at BioCentury Publications, Inc.

Chief Financial Officer at Evelo Biosciences, Inc.

Paths to Codiak Biosciences, Inc.
Potential Connections via
Relationship Science
You
Codiak Biosciences, Inc.
Recent Transactions
Details Hidden

Codiak Biosciences, Inc. raised money in a private placement transaction

Details Hidden

Codiak Biosciences, Inc. raised money in a private placement transaction

Clients

• About Us • Mission & Values • Management Team • Board of Directors • Board Committees • Commercial Capabilities • Corporate Responsibility • Ethical Sales & Marketing • Drug Safety & Medical Info • Physician Data Restriction Program • California Compliance Declaration • Stories • What’s in a Name? • Business Development • Locations ABOUT US Jazz Pharmaceuticals plc is an international specialty biopharmaceutical company dedicated to helping patients with unmet medical needs. We identify, develop and commercialize innovative products in focused therapeutic areas, with a strong commercial focus and expertise in narcolepsy, oncology, pain and psychiatry. Our marketed product portfolio includes: XYREM® (sodium oxybate), ERWINAZETM (asparaginase Erwinia chrysanthemi), PRIALT® (ziconotide) solution, intrathecal infusion, FAZACLO® (clozapine, USP) LD and HD , and LUVOX CR® (fluvoxamine maleate). The product information on XYREM, ERWINAZE, PRIALT, FAZACLO LD, FAZACLO HD and LUVOX CR is intended only for residents of the United States. For more information, including complete prescribing information and boxed warnings, click on the product names above. Please visit www.EUSAPharma.com for more information about our international division, EUSA Pharma, and our products marketed outside the U.S. We plan to build upon our portfolio of products through acquisition and/or in-licensing activities, and leveraging our unique commercial expertise. As we evaluate additional acquisition and in-licensing opportunities, we work closely with healthcare professionals and patient advocates to identify significant treatment gaps where Jazz Pharmaceuticals’ unique approach to patient care and patient-focused products may be able to bring a new therapeutic option to the market where none existed previously.

Key Stats and Financials As of 2018
Market Capitalization
Total Enterprise Value
Earnings Per Share
Revenue
$0
EBITDA
$-36.6M
Investors
Details Hidden

FMR LLC (Fidelity Management and Research) or Fidelity Investments is an American multinational financial services corporation. It is one of the largest mutual fund and financial services groups in the world. Founded in 1946, the company has since served North American investors. Fidelity Ventures is its venture capital arm. Fidelity International Limited (FIL), was an international affiliate founded in 1969, serving most countries in the rest of the world. In September 2011, FIL was rebranded as 'Fidelity Worldwide Investment'. Fidelity Investments manages a large family of mutual funds provides fund distribution and investment advice services, as well as providing discount brokerage services, retirement services, wealth management, securities execution and clearance, life insurance and a number of other services.

Details Hidden

State of Alaska is a U.S. state situated in the northwest extremity of the North American continent. Bordering the state to the east are the Canadian territory of Yukon and the Canadian province of British Columbia; to the north is the Arctic Ocean; and to the west and south is the Pacific Ocean with Russia farther west across the Bering Strait. Alaska is the largest state in the United States by area, the 4th least populous, and the least densely populated of the 50 states in the U.S. Approximately half of Alaska’s residents live within the Anchorage metropolitan area. Its economy is dominated by the oil, natural gas, and fishing industries, resources which it has in abundance. Tourism is also a significant part of the economy. Although it had been occupied for thousands of years by indigenous people, from the 18th century onward, European powers considered the territory of Alaska ripe for exploitation and trade. The area went through several administrative changes before becoming organized as a territory on May 11, 1912. It was admitted as the 49th state of the U.S. on January 3, 1959.

Details Hidden

Casdin Capital invests in early stage companies located in the US. The firm targets companies operating in the fields of life sciences and healthcare industry.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Codiak Biosciences, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Codiak Biosciences, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Codiak Biosciences, Inc..